TGFB1 and melanoma: Our study describes that sublethal exposure to Doxorubicin reprograms the extracellular vesicles profile of melanoma cells, enhancing their biogenesis and enriching their cargo with profibrotic and immunomodulatory mediators, notably TGF-β.